Accuracy of optical spectroscopy for the detection of cervical intraepithelial neoplasia: Testing a device as an adjunct to colposcopy
Authors:
- Scott B. CantorSCScott B. Cantor
- Jose‐Miguel YamalJYJose‐Miguel Yamal
- Martial GuillaudMartial Guillaud
- Dennis D. CoxDCDennis D. Cox
- E. Neely AtkinsonEAE. Neely Atkinson
- John L. BenedetJBJohn L. Benedet
- Dianne MillerDMDianne Miller
- Thomas EhlenTEThomas Ehlen
- Jasenka MatisicJMJasenka Matisic
- Dirk van NiekerkDNDirk van Niekerk
- Andrea MilbourneAMAndrea Milbourne
Open Access
- 9 September 2010
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 128 (5) , 1151-1168
Abstract
Testing emerging technologies involves the evaluation of biologic plausibility, technical efficacy, clinical effectiveness, patient satisfaction, and cost‐effectiveness. The objective of this study was to select an effective classification algorithm for optical spectroscopy as an adjunct to colposcopy and obtain preliminary estimates of its accuracy for the detection of CIN 2 or worse. We recruited 1,000 patients from screening and prevention clinics and 850 patients from colposcopy clinics at two comprehensive cancer centers and a community hospital. Optical spectroscopy was performed, and 4,864 biopsies were obtained from the sites measured, including abnormal and normal colposcopic areas. The gold standard was the histologic report of biopsies, read 2 to 3 times by histopathologists blinded to the cytologic, histopathologic, and spectroscopic results. We calculated sensitivities, specificities, receiver operating characteristic (ROC) curves, and areas under the ROC curves. We identified a cutpoint for an algorithm based on optical spectroscopy that yielded an estimated sensitivity of 1.00 [95% confidence interval (CI) = 0.92–1.00] and an estimated specificity of 0.71 [95% CI = 0.62–0.79] in a combined screening and diagnostic population. The positive and negative predictive values were 0.58 and 1.00, respectively. The area under the ROC curve was 0.85 (95% CI = 0.81–0.89). The per‐patient and per‐site performance were similar in the diagnostic and poorer in the screening settings. Like colposcopy, the device performs best in a diagnostic population. Alternative statistical approaches demonstrate that the analysis is robust and that spectroscopy works as well as or slightly better than colposcopy for the detection of CIN 2 to cancer.Keywords
Funding Information
- National Cancer Institute (P01-CA-82710-09)
- National Biomedical Imaging Branch
This publication has 88 references indexed in Scilit:
- A Bayesian Hierarchical Model for Classification with Selection of Functional PredictorsBiometrics, 2010
- HPV Screening for Cervical Cancer in Rural IndiaNew England Journal of Medicine, 2009
- The Performance of Human Papillomavirus High-Risk DNA Testing in the Screening and Diagnostic SettingsCancer Epidemiology, Biomarkers & Prevention, 2008
- A new HPV-DNA test for cervical-cancer screening in developing regions: a cross-sectional study of clinical accuracy in rural ChinaThe Lancet Oncology, 2008
- Model-based analysis of reflectance and fluorescence spectra for in vivo detection of cervical dysplasia and cancerJournal of Biomedical Optics, 2008
- Maximizing the diversity of participants in a phase II clinical trial of optical technologies to detect cervical neoplasiaGynecologic Oncology, 2007
- Light Scattering from Collagen Fiber Networks: Micro-Optical Properties of Normal and Neoplastic StromaBiophysical Journal, 2007
- Absolute quantitative real-time polymerase chain reaction for the measurement of human papillomavirus E7 mRNA in cervical cytobrush specimensInfectious Agents and Cancer, 2007
- Against which human papillomavirus types shall we vaccinate and screen? the international perspectiveInternational Journal of Cancer, 2004
- Effect of probe pressure on cervical fluorescence spectroscopy measurementsJournal of Biomedical Optics, 2004